Lactated Ringer's Solution — Competitive Intelligence Brief

Lactated Ringer's Solution (Lactated Ringer's Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid intravenous fluid. Area: Critical Care / Fluid Resuscitation.

marketed Crystalloid intravenous fluid Critical Care / Fluid Resuscitation Small molecule

Target snapshot

Lactated Ringer's Solution (Lactated Ringer's Solution) — McGill University Health Centre/Research Institute of the McGill University Health Centre. Lactated Ringer's Solution is a crystalloid intravenous fluid that replaces lost fluids and electrolytes to restore intravascular volume and maintain physiological balance.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lactated Ringer's Solution TARGET	Lactated Ringer's Solution	McGill University Health Centre/Research Institute of the McGill University Health Centre	marketed	Crystalloid intravenous fluid
Lactated Ringer	Lactated Ringer	Fayoum University Hospital	marketed	Crystalloid intravenous fluid
Ringer lactato	Ringer lactato	Federal University of Juiz de Fora	marketed	Crystalloid intravenous fluid
fluidotherapy with ringer-lactate	fluidotherapy with ringer-lactate	Medical University of Vienna	marketed	Crystalloid intravenous fluid
Plasma-lyte (static group)	Plasma-lyte (static group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
sodium bicarbonate Ringer's solution	sodium bicarbonate Ringer's solution	The First Affiliated Hospital with Nanjing Medical University	marketed	Crystalloid intravenous fluid / electrolyte solution
Plasma-lyte (dynamic group)	Plasma-lyte (dynamic group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid intravenous fluid class)

1. Fayoum University Hospital · 1 drug in this class
2. Federal University of Juiz de Fora · 1 drug in this class
3. Fundación Cardioinfantil Instituto de Cardiología · 1 drug in this class
4. McGill University Health Centre/Research Institute of the McGill University Health Centre · 1 drug in this class
5. Medical University of Vienna · 1 drug in this class
6. Nationwide Children's Hospital · 1 drug in this class
7. Rigshospitalet, Denmark · 1 drug in this class
8. Scientific Institute San Raffaele · 1 drug in this class